Lakeside Dr., Yorktown Heights, NY, United States of America

Dennis D Pietronigro

USPTO Granted Patents = 4 


Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 59(Granted Patents)


Location History:

  • Lakeside Dr., Yorktown Heights, NY (US) (1991)
  • Yorktown Heights, NY (US) (1992)
  • Katonah, NY (US) (2004)
  • Clinton, NJ (US) (2011)

Company Filing History:


Years Active: 1991-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Dennis Pietronigro

Introduction

Dennis Pietronigro is a notable inventor based in Clinton, NJ, recognized for his significant contributions to medical innovations, particularly in the treatment of lymphomas. With one patented invention, Pietronigro stands out in the field of oncology, addressing critical patient needs through his research.

Latest Patents

Pietronigro holds a patent for "Methods for treating lymphomas in certain patient populations and screening patients for said therapy." This invention reveals innovative techniques for predicting how patients with lymphoma may respond to a specific therapy regimen involving 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione. His method utilizes prognostic factors, including disease burden and absolute lymphocyte count, to tailor treatments effectively, potentially enhancing patient outcomes significantly.

Career Highlights

Dennis Pietronigro is associated with Celgene Corporation, a company known for its commitment to innovative therapies in the field of oncology and other critical domains. His work emphasizes the importance of personalized medicine in treating complex diseases like lymphoma, thereby improving survival rates and quality of life for patients.

Collaborations

Throughout his career, Pietronigro has collaborated with several esteemed colleagues, including Annette Ervin-Hayes and Jerome B. Zeldis. These partnerships highlight the collaborative spirit of research and innovation that is vital in the medical field, fostering an environment where groundbreaking ideas can flourish.

Conclusion

Dennis Pietronigro's contributions through his patented methods demonstrate a clear advancement in the treatment of lymphomas and patient care. His affiliation with Celgene Corporation and collaborative efforts with notable professionals in the industry underscore the collective pursuit of innovative solutions in medicine. As research and development progress, the impact of such inventions will undoubtedly play a crucial role in shaping future treatment paradigms for lymphoma patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…